FDA Inspection
Genecell International, LLCGenecell International, LLC – FDA Inspection, Sep 19, 2018
Record Details
This FDA Inspection record concerns Genecell International, LLC, with an inspection on September 19, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f410a567-0d04-466e-a61d-44236ae22c8c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1066756
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 1271.195(b)Corrective actions
- 21 CFR 1271.195(a)(1)Temperature and humidity controls
- 21 CFR 1271.200(a)Cleaned, sanitized per established schedules
- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
- 21 CFR 1271.230(a)Validation & approval--established procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Genecell International, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 13, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Genecell International, LLC
- FDA Inspection 799056 - 2012-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.